Literature DB >> 20579587

Novel treatment for chylothorax after esophagectomy with 50% glucose pleurodesis.

Yulong Chen1, Changyuan Li, Lijun Xu, Hongjing Lin, Youbin Cui, Jean Deslauriers.   

Abstract

Chylothorax is characterized by the presence of chyle in the pleural space and cardiothoracic surgery accounts for nearly half of all the cases. Treatment of chylothorax has traditionally been nonoperative, with alternative medical therapies involving the administration of octreotide or pleurodesis. Pleurodesis with chemical agents has previously been reported, but never with 50% glucose and 0.1% xylocaine. Herein, we report a successful method of intrapleural instillation of 50% glucose and 0.1% xylocaine to treat chylothorax. Five patients treated with this method were all recovered rapidly. This method can generate extensive adherence and prevent the effusion of the chylous fluid with minor side effects. Copyright (c) 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579587     DOI: 10.1016/j.avsg.2009.10.021

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Intraoperative mechanical and chemical pleurodesis with 50 % glucose solution for secondary spontaneous pneumothorax in patients with pulmonary emphysema.

Authors:  Takuma Tsukioka; Kiyotoshi Inoue; Hiroko Oka; Shinjiro Mizuguchi; Ryuhei Morita; Noritoshi Nishiyama
Journal:  Surg Today       Date:  2013-01-31       Impact factor: 2.549

2.  A modified pleurodesis in treating postoperative chylothorax.

Authors:  Yutian Lai; Xi Zheng; Yong Yuan; Tian-Peng Xie; Yong-Fan Zhao; Zi-Jiang Zhu; Yang Hu
Journal:  Ann Transl Med       Date:  2019-10

3.  Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothorax.

Authors:  Kosuke Fujino; Yamato Motooka; Takamasa Koga; Hironobu Osumi; Eri Matsubara; Hidekatsu Shibata; Koei Ikeda; Kenji Shiraishi; Takeshi Mori; Koji Hayashi; Kentaro Yoshimoto; Jyoeji Wakimoto; Ichiro Kubota; Makoto Suzuki
Journal:  Surg Today       Date:  2015-07-24       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.